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strated CR. MCE and SPECT showed sensitivities of 80% and 75% (p=NS) respectively
for the detection of CR, the specificities were also similar (65% vs. 69% respectively).
MCE had an improved specificity (84%) when only segments with homogenous contrast
opacification were considered viable compared to 78% with normal tracer uptake on
SPECT. On a patient basis, the extent and intensity of contrast opacification by MCE was
significantly higher in the 25 patients with CR when compared to those without (p=0.008),
no significant difference was noted in SPECT (p=0.06). MCE was superior to SPECT for
predicting an improvement in regional ventricular function in the infarct related area
(p=0.002 vs 0.02). Conclusions: MCE was superior to SPECT for the identification of
myocardial viability in patients following AMI. MCE is a valid alternative to SPECT for the
assessment of viability following AMI.
1036-157 Quantification of Absolute Myocardial Perfusion by 
Contrast Echocardiography: Algorithm, In Vitro and In 
Vivo Validation
Rolf Vogel, Andreas Indermuehle, Philipp Kaufmann, Christian Seiler, University 
Hospital, Bern, Switzerland, University Hospital Zuerich, Zuerich, Switzerland
Background: Absolute tissue perfusion (ml/min/g) is the gold standard for the functional
assessment of the microcirculation. To date, absolute myocardial perfusion in humans
can only be obtained by positron emission tomography (PET).
Based on a volumetric model of ultrasound contrast agent (UCA) kinetics for the descrip-
tion of UCA refill curves following ultrasound-induced microsphere destruction, we devel-
oped an algorithm for absolute perfusion measurements using myocardial contrast
echocardiography (MCE). Objectives of this study were to validate this algorithm in vitro
(1) and in vivo (2) as well as to demonstrate its generalization (3).
Methods: The spatial form of the continuity equation yielded absolute perfusion: Π=β×µ/
ρ, where ρ is tissue density. Parameter β and µ indicate the rate constant of rise of the
refill curve and the intravascular volume ratio (IVR) that were calculated from refill
sequences recorded by real-time MCE during constant intravenous UCA infusion. (1) A
hemodialysis filter mimicking microcirculation (IVR=0.213) was perfused with saline by a
pump at flow rates between 10 and 200ml/min. (2) Assessment of regional myocardial
perfusion in 14 healthy volunteers by MCE and PET. (3) Evaluation of regional renal and
cerebral perfusion in a healthy volunteer by MCE.
Results: (1) For flow velocities from 0.4–8.6mm/s, mean (SD) µ was 0.219 (0.023).
Parameter β correlated linearly with pump flow Qpump (r2=0.98). Spatial integration of Π
assessed by MCE yielded total phantom volume flow QMCE that served as an estimate of
Qpump (QMCE=0.90Qpump+0.45, r2=0.96, SEE=8.26). (2) Perfusion analysis by MCE was
successful in 182 of 224 segments. Linear regression analysis showed good agreement
between MCE and PET perfusion data (ΠMCE=0.902ΠPET+0.076, r2=0.88, SEE=0.134).
(3) Renal cortical and cerebral perfusion was 2.91ml/min/g and 0.91ml/min/g, respec-
tively, and were in good agreement with published data.Conclusion: MCE in conjunction
with the presented algorithm allows the measurement of absolute myocardial perfusion
and, likely, absolute renal and cerebral perfusion and thus may offer new capabilities to
study cardio-, reno- and cerebrovascular diseases.
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BACKGROUND: High dose dipyridamole contrast echocardiography with intermittent
harmonic imaging (MCE) has shown high sensitivity and specificity for diagnosis of myo-
cardial perfusion defects (MPD) in comparison with simultaneous sesta Mibi SPECT. The
prognostic value of MCE to predict coronary events was not studied yet. PURPOSE: To
demonstrate the prognostic value of reversible perfusion defects detected by dipy-
ridamole MCE´s, to predict mortality and coronary events. POPULATION AND METH-
ODS: 50 pts from 2 laboratories referred to dipyridamole SPECT were studied using
MCE and simultaneous sesta Mibi SPECT and then followed up for 39 months ( 25 - 46
months) looking at death, AMI, unstable angina, cardiac surgery or PTCA. Pts cohort had
32 males, medium age 68 y/o +- 11 y/o. 2 nd Harmonics with Mechanical index 0.5-0.7
and 1/1, 1/3 and 1/5 end systolic triggering was applied, in apical 2, 3 and 4 chambers
views, before and after 0.84 mg/kg dipyridamole injection. MCE ´s perfusion data were
analyzed blindly from SPECT results. MPD were considered when defects persist
beyond the 1/3 trigger interval, SPECT perfusion defects (SPD) were independently rec-
ognized by nuclear cardiologists. Reversible MPD and SPD were those perfusion defects
present only after dipyridamole injection. RESULTS: 9 pts had events during follow up (2
deaths, 11 PTCA, 3 cardiac surgery and 8 unstable angina). There were 26 pts without
any MPD who had 4 events; 15 pts with fixed MPD showed 1 event (NS). 9 pts had
reversible MPD and showed 4 events p< 0.02 vs patients without MPD and fixed MPD. 24
pts without any SPD had 3 events; 16 pts had fixed SPD and showed 2 event (NS). 10
pts with reversible SPD showed 4 events p< 0.04 vs pts without SPD and fixed SPD.
Kaplan Meier actuarial survival curves showed differences in events rate since 3 months
after the studies, for reversible MPD and SPD ( Log Rank test p< 0.04 and p< 0.05
respectively) and fixed SPD or MPD did not showed significant differences in comparison
with pts without any defects . CONCLUSION: Reversible perfusion defects detected in
high dose Dipiridamole stress MCE, are predictive for coronary events.
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Background. It has been reported that an increase in C-reactive protein (CRP) level is
associated with left ventricular (LV) remodeling in patients with AMI, but its underlying
mechanism remains unknown. We hypothesized that inflammation impairs capillary func-
tion and, thus, impairs healing process of infarct myocardium, resulting in LV remodeling.
Methods and Results. We assessed tissue-level perfusion with myocardial contrast
echocardiography in consecutive 114 patients with first Q-wave AMI admitted within 24
hours of onset of AMI. They underwent primary coronary intervention. Serial measure-
ments of serum CRP levels were performed every 24 hours. Left ventriculography was
performed 4 weeks later to measure left ventricular end-diastolic volume index (LVEDVI).
LVEDVI was significantly higher in the no-reflow group than the good-reflow group (66 +/-
18 versus 59 +/- 12 ml/m2,p<0.01). The no-refow group had higher CRP level than the
good-reflow group (10.0 +/- 4.6 versus 6.4 +/- 4.7 mg/dl, p<0.001). Re-elevation of ST
segment after reperfusion was more frequently found in the no-reflow group than the
good-reflow group (63 % versus 26 % ,p<0.001). Multivariate logistic analysis showed
that peak CRP and ST re-elevation were independent determinants of no-reflow phe-
nomenon.
Conclusion. Tissue inflammation along with reperfusion injury impairs tissue-level perfu-
sion. Microvascular dysfunction may play an important role on the development of LV
remodeling after reperfused AMI.
1036-160 Collateral Blood Flow in the Presence of the Persistently 
Occluded Infarct-Related Artery Can Be Accurately 
Predicted by Myocardial Contrast Echocardiography
Rajesh Janardhanan, Leah Burden, Roxy Senior, Northwick Park Hospital, Harrow, 
United Kingdom
Background: Adequate collateral blood flow (CBF) at rest can sustain myocardial viabil-
ity despite persistent occlusion of the infarct related artery (IRA) in acute myocardial inf-
arction (AMI). This has both therapeutic and prognostic implications. Studies addressing
the value of intravenous myocardial contrast echocardiography (MCE) to detect CBF
after AMI in humans are limited.
Methods: Seventy consecutive patients with AMI underwent low-power intravenous MCE
using Sonovue® infusion 7-10 days after thrombolysis. Myocardial perfusion detected by
MCE was analysed (qualitatively and quantitatively) in the akinetic segments in 20 (29%)
patients with occluded IRA who subsequently underwent revascularization. Contractile
reserve, which is a marker of myocardial viability, was assessed with low dose dob-
utamine 12 weeks after mechanical revascularization.
Results: Of the 102 (32%) akinetic segments, 37 (36%) showed contractile reserve.
Contractile reserve was present in 24 (83%) of the 29 segments with homogenous con-
trast opacification and absent in 60 (82%) of the 73 segments with reduced/absent opaci-
fication. Quantitative peak contrast intensity, myocardial blood velocity and the
myocardial blood flow were significantly higher (p<0.0001) in the segments with contrac-
tile reserve when compared to those without contractile reserve (fig).
Conclusion: MCE may be used as a reliable bedside technique for the accurate evalua-
tion of collateral blood flow in presence of an occluded IRA after AMI.
Multivariate Logistic Regression analysis for No-reflow phenomenon
Relative risk 95% CI P value
PCPK 1.00 1.001-1.002 0.0001
ST re-elevation 8.45 1.45-49.81 0.018
Anterior MI 5.73 1.31-24.86 0.021
Peak CRP 1.34 1.04-1.73 0.024
Hyperlipidemia 0.49 0.11-2.20 0.348
Wall motion score(day-1) 1.03 0.88-1.20 0.750
Killip>2 0.95 0.09-10.26 0.966
